Skip to main content

pneumonia Archives

Pneumonia vaccine reducing pediatric admissions: report

Nov. 6, 2014—In Tennessee, the introduction in 2010 of a new pneumococcal vaccine for infants and young children coincides with a 27 percent decline in pneumonia hospital admissions across the state among children under age 2.

Read more


Cutting-edge research to be showcased in May

May. 1, 2014—Potentially “game-changing” research at Vanderbilt University on infectious diseases, population health and health policy will be showcased during two interactive presentations May 15 and May 22. A segment of the Flexner Discovery Lecture Series, the new “Vanderbilt Cutting-edge Discovery” discussions are highlights of recent presentations to the Vanderbilt Biomedical Science Advisory Board, a group of...

Read more


Flu boosts pneumococcal colonization

Mar. 27, 2014—Influenza and parainfluenza infections – but not other respiratory viruses – increase the risk of acquiring pneumococcal bacteria, the most common cause of severe pneumonia.

Read more


Penicillin equally effective as ‘big gun’ antibiotics for treating less severe childhood pneumonia, Vanderbilt study shows

Dec. 9, 2013—Children hospitalized for pneumonia have similar outcomes, including length of stay and costs, regardless of whether they are treated with “big gun” antibiotics such as ceftriaxone or cefotaxime or more narrowly focused antibiotics such as ampicillin or penicillin.

Read more


Infant vaccine for pneumonia helps protect elderly

Jul. 11, 2013—Children who receive a vaccine to prevent blood and ear infections may be reducing the spread of pneumonia to the rest of the population, especially their grandparents and other older adults.

Read more


Pneumonia vaccine for children to be tested in older adults

Oct. 11, 2012—Vanderbilt is taking part in a national study to test in older adults the use of a vaccine designed to protect children against a common cause of pneumonia.

Read more


Researchers spot Achilles’ heel in respiratory virus

Apr. 13, 2012—A new viral protein structure could jump-start vaccine development for two leading causes of lower respiratory disease in children and elderly adults.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more